PAPPA antibody (AA 351-523)
Quick Overview for PAPPA antibody (AA 351-523) (ABIN7874253)
Target
See all PAPPA AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 351-523
-
Purpose
- PAPPA Antibody / Pappalysin-1
-
Purification
- Protein G affinity chromatography
-
Immunogen
- A portion of amino acids 351-523 from the human protein was used as the immunogen for the PAPPA antibody.
-
Isotype
- IgG2b, kappa
-
-
-
-
Application Notes
-
The stated application concentrations are suggested starting points. Titration of the PAPPA antibody may be required due to differences in protocols and secondary/substrate sensitivity.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Prediluted in 1X PBS, 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide, *For IHC use only*
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the PAPPA antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- PAPPA (Pregnancy-Associated Plasma Protein A, Pappalysin 1 (PAPPA))
-
Alternative Name
- PAPPA
-
Background
- The PAPPA gene encodes a secreted metalloproteinase which cleaves insulin-like growth factor binding proteins (IGFBPs). Following IGFBP cleavage, insulin growth factors dissociate from IGFBPs and bind to IGF receptors, resulting in activation of the IGF pathway. The encoded protein plays a role in bone formation, inflammation, wound healing and female fertility. Enhanced expression of this protein is associated with diabetic nephropathy in human patients and this protein may promote tumor invasion and growth in various human cancers. [RefSeq]
-
UniProt
- Q13219
Target
-